BioSpace News Archive

Syndax Pharmaceuticals announced that Michael A. Metzger, Chief Executive Officer of Syndax, will participate in a fireside chat at the Stifel Healthcare Conference on Tuesday, November 14, 2023, at 4:45 p.m. ET.

Marinus Pharmaceuticals, Inc. announced the initiation of the Marinus Access Program, a global managed access program for ZTALMY® oral suspension CV.

Adicet Bio, Inc. announced that Chen Schor, President and Chief Executive Officer, will present at the 2023 Jefferies London Healthcare Conference being held from November 14-16, 2023 in London.

Glaukos Corporation announced that its management is scheduled to participate in the Stifel Healthcare Conference on Tuesday, November 14, 2023, at 10:55 a.m. ET in New York City.

Recently, CPHI Worldwide 2023 was successfully held in Barcelona, Spain. Kexing Biopharm exhibited more than ten kinds of high-quality medical products in the fields of tumor, autoimmune, anti-virus, etc., including Infliximab, Adalimumab, Bevacizumab, and Trastuzumab, etc., which attracted many customers to stop by for negotiation.

ADC Therapeutics SA announced that on October 10, 2023, it received a notice from the New York Stock Exchange that the Company is not in compliance with the continued listing minimum price criteria set forth in Section 802.01C of the NYSE Listed Company Manual, which requires listed companies to maintain an average closing share price of at least $1.00 over a consecutive 30 trading-day period.

Matinas BioPharma Holdings, Inc. announces positive results from an in vivo animal study of an oral LNC formulation of docetaxel, a well-known chemotherapeutic agent used in the management of multiple metastatic and unresectable tumors.

Sage Therapeutics, Inc. reported business highlights and financial results for the third quarter ended September 30, 2023.

Zimmer Biomet Holdings, Inc. reported financial results for the quarter ended September 30, 2023.

KalVista Pharmaceuticals, Inc. announced it will participate in a fireside chat at the following investor conferences.